Synchneuro, Inc.

Revolutionizing health monitoring through brain signals

San Francisco, United States · Founded 2021 · $3.0M raised

Employees
1–10
Founded
2021
Business Model
B2C
Total Funding
$3.0M
Last Round
$3.0M SeedNov 2025
Rounds
1

About

SynchNeuro is developing the world's first non-invasive, brain-based continuous glucose monitor. Its discreet behind-the-ear EEG sensor analyzes brain signals to track glucose levels, sleep quality, and other metabolic metrics without needles or skin puncture. Machine learning models translate brainwave patterns into real-time metabolic health insights.

Summary

Synchneuro, Inc. is a Medtech company based in San Francisco, United States, founded in 2021. It has raised $3.0M in total across 1 round, most recently a $3.0M Seed round in Nov 2025. Investors include Boomerang Ventures and Plug and Play.

Tech & App Stack

1 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundNov 2025
$3.0M

Investors

Similar Companies